AbbVie
NYSE: ABBV
$263.00
+0.50
(+0.19%)
Live
as on
AbbVie Stock Performance
as on September 18, 2026 at 6:12 am IST
Day's Low
Day's High
$260.88$263.73
0.81%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
$190.75$267.4727.47%
Downside
1.70%
Upside
AbbVie share price movements today
- Previous Close
- $262.51
- Open
- $262.73
- Volume
- 840.5K
- Market Cap
- $462.6B
- Dividend Yield
- 2.60%
- Day's Low - High
- $260.88 - $263.73
- 52 Week Low - High
- $190.75 - $267.47
AbbVie Historical Returns
- 1 Month Return
- + 4.87 %
- 3 Month Return
- + 18.66 %
- 1 Year Return
- + 18.89 %
- 3 Year Return
- + 72.57 %
- 5 Year Return
- + 143.67 %
AbbVie Stock Fundamentals & Key Indicators
Check AbbVie market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$462.6B
EPS (TTM)
3.55
Dividend Yield
2.60%
Quarterly Earnings Growth YOY
2.90%
PE Ratio (TTM)
74.1
Industry PE ratio
25.75
PEG Ratio
1.0857173741215504
EBITDA
21.2B
Revenue (TTM)
64.4B
Profit Margin
71.48%
Return On Equity TTM
-136.50%
AbbVie Stock Valuation
Track how AbbVie P/E has moved over time to understand its valuation trends.
AbbVie in the last 5 years
Lowest (20.76x)
December 31, 2021
Industry (25.75x)
December 31, 2025
Today (96.41x)
December 31, 2025
Highest (96.41x)
December 31, 2025
Today’s Price to Earnings Ratio: 96.41x
AbbVie vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of AbbVie with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $462.6B | 143.67% | 74.1 | 71.48% | 2.60% | |
| BUY | $1.1T | 394.49% | 38.04 | 83.40% | 0.59% | |
| BUY | $641.8B | 62.23% | 30.89 | 67.91% | 1.98% | |
| BUY | $357.4B | 102.16% | 115.96 | 4.77% | 2.36% | |
| BUY | $253.9B | 46.59% | 24.33 | 79.27% | 2.00% |
Stock Returns calculator for AbbVie Stock including INR - Dollar returns
The AbbVie stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
AbbVie investment value today
Current value as on today
₹1,30,217
Returns
₹30,217
(+30.22%)
Returns from AbbVie Stock
₹19,107 (+19.11%)
Dollar Impact
₹11,110 (+11.11%)
Analyst Recommendation on AbbVie Stock
Based on 23 analysts
82.61%
Buy
17.39%
Hold
0.00%
Sell
Based on 23 analysts, 82.6086956521739% of analysts recommend a 'BUY' rating for AbbVie. Average target price of $278.61
AbbVie Share Price Target
Get share price movements and forecasts by analysts on AbbVie.
What analysts predicted
5.6%UPSIDE
Target Price
$278.61
Current Price
$263
Analyzed by
23 Analysts
Target
$278.61
AbbVie target price $278.61, a slight upside of 5.6% compared to current price of $263. According to 23 analysts rating.
Indian Investors' Interest in AbbVie Stock
Investment in AbbVie Shares on INDmoney has dropped by -2.39% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for AbbVie Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
AbbVie Quarterly Profit & Loss
All numbers in Millions USD
AbbVie Annual Profit & Loss
All numbers in Millions USD
AbbVie Quarterly Cash Flow
All numbers in Millions USD
AbbVie Annual Cash Flow
All numbers in Millions USD
AbbVie News & Key Events
Today's Timeline - 17 September
Thu, 05:40 PM
-AbbVie’s Allergan Aesthetics presents significant skin quality improvements from new skincare studies at the Science of Skin Summit.
Thu, 05:41 PM
-AbbVie reports strong revenue growth, driven by SKYRIZI and RINVOQ, despite HUMIRA's decline under biosimilar competition.
Thu, 10:00 PM
-AbbVie updates on ABBV-444 trial for dry eye treatment, aiming for market entry and potential revenue growth.
Insights on AbbVie
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
AbbVie Inc. has shown strong profit growth over the last two quarters. In the most recent quarter, the company's net profit increased significantly from $699 million to $3.61 billion. This represents an average growth rate of 80.7% per quarter.
- POSITIVE IMPACT
Revenue Rich
AbbVie Inc. has shown positive revenue growth over the last two quarters. In the most recent quarter, the revenue increased from $15.00 billion to $16.99 billion, reflecting an average growth rate of 11.7% per quarter.
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ABBV has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, ABBV stock has moved up by 2.9%
NO EFFECTAgainst Peers
In the last 1 year, Merck & Co., Inc. has given 78.6% return, outperforming this stock by 59.7%
About AbbVie
| Organisation | AbbVie |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Scott T. Reents |
| E-voting on shares | Click here to vote |
Key Management of AbbVie
Name | Title |
|---|---|
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Dr. Azita Saleki Ph.D. | Executive VP & COO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Scott T. Reents | Executive VP & CFO |
FAQs
What is AbbVie share price today?
AbbVie share price today is $263.00 as on . AbbVie share today touched a day high of $263.73 and a low of $260.88.
What is the 52 week high and 52 week low for AbbVie share?
AbbVie share touched a 52 week high of $267.47 on and a 52 week low of $190.75 on . AbbVie stock price today i.e. is trending at $263.00,which is 1.67% down from its 52 week high and 37.88% up from its 52 week low.
What is AbbVie's market capitalisation today?
AbbVie market capitalisation is $0.46T as on .
How to invest in AbbVie Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for AbbVie on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbbVie Shares that will get you 0.0057 shares as per AbbVie share price of $263.00 per share as on September 18, 2026 at 12:42 am IST.
What is the minimum amount required to buy AbbVie Stock (ABBV) from India?
Indian investors can start investing in AbbVie (ABBV) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in AbbVie stock (as per the Rupee-Dollar exchange rate as on ).
Based on AbbVie share’s latest price of $263.00 as on September 18, 2026 at 12:42 am IST, you will get 0.0380 shares of AbbVie. Learn more about
fractional shares .
What are the returns that AbbVie has given to Indian investors in the last 5 years?
AbbVie stock has given 143.67% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?